CEP-7055

CAT: 0931-MF-0143953-01Size: 25 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0143953-01Size:25 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
402857-58-3
Target
Others|||VEGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Others|||Angiogenesis
Bioactivity
CEP-18770 is an orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin-like activity of the proteasome, with potential antineoplastic activity. Proteasome inhibitor CEP 18770 represses the proteasomal degradation of a variety of proteins, including inhibitory kappaBalpha (IkappaBalpha), resulting in the cytoplasmic sequestration of the transcription factor NF-kappaB; inhibition of NF-kappaB nuclear translocation and transcriptional up-regulation of a variety of cell growth-promoting factors; and apoptotic cell death in susceptible tumor cell populations. In vitro studies indicate that this agent exhibits a favorable cytotoxicity profile toward normal human epithelial cells, bone marrow progenitors, and bone marrow-derived stromal cells relative to the proteasome inhibitor bortezomib. The intracellular protein IkappaBalpha functions as a primary inhibitor of the proinflammatory transcription factor NF-kappaB.
Smiles
C(CCOC(CN(C)C)=O)N1C=2C(=C3C(=C4C2CC=5C4=CC=CC5)C(=O)NC3)C=6C1=CC=C(COC(C)C)C6
Molecular Formula
C32H35N3O4
Molecular Weight
525.64
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0042680-01CEP-2563
MF-0016615-01CEP-33779
MF-0045569-01CEP-28122
MF-0045246-01CEP-8983
MF-0143365-01CEP-14513
MF-0100814-01CEP-37248
MF-0096380-01CEP-37440
MF-0051941-01CEP-1612
MF-0098347-01CEP-11981
MF-0111383-01CEP-751

Alternative Products

CatalogName
HY-13590CEP-7055
8108/5CEP
2332323WSE-7055 EzRun TG
MBS3844777-01CEP-40783
M10648-01CEP-32496
M10107-01CEP-28122
GW6518-5mgCEP-33779
HY-123172CEP-2563
MBS130677-01CEP-37440
MBS5804885CEP-9722

Popular Products